FDA Drug Application (072011) for TRIAMTERENE AND HYDROCHLOROTHIAZIDE by SANDOZ

Back to FDA Applications sponsored by SANDOZ

Application Number072011
Product Number001
FormTABLET;ORAL
Dosage50MG;75MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRIAMTERENE AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; TRIAMTERENE



Back to FDA Applications sponsored by SANDOZ

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.